FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
#1 | ||
|
|||
Member
|
It is from WebMD
http://www.webmd.com/multiple-sclero...wnl_mls_081911 I was flabbergasted!! Makes me wonder why anyone would put ourselves through the side effects, and not knowing the long-term effects for an average of one or two quality month in our LIFETIME!! For example, the study found that on average, patients taking Copaxone for 10 years could expect the drug to add less than one quality-adjusted month to their lives compared to patients who were only getting supportive therapy to control symptoms. Patients taking Avonex, Betaseron, and Rebif gained about two quality-adjusted months compared to those getting supportive care. The study also looked at how likely the drugs were to prevent relapses. Those taking disease-modifying drugs spent on average nearly six out of 10 years with no relapses, compared to five years with no relapses for those who did not take disease-modifying drugs. However, the effectiveness varied significantly among individuals, with some experiencing double the improvements and being able to live independently and prolong their employment and others not getting any meaningful effect.
__________________
Dx: RRMS Jan 2010; LDN: March 2010-Dec 2010; Aug 2012-Nov 2012 Tysabri: Feb 2011-March 2011 reaction Gilenya: August 2011 reaction Copaxone: October 2011 reaction Tecfidera: May 2013 reaction |
||
![]() |
![]() |
|
|
![]() |
||||
Thread | Forum | |||
You HAVE to read this!! | The Stumble Inn | |||
Has anyone read? | The Stumble Inn | |||
Has any one read this study? Tricyclics | Peripheral Neuropathy |